/GDRX
GDRX Stock - GoodRx Holdings, Inc.
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$2.86-0.69%
$0.02 (-0.69%) • Jan 13
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).95
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.62
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+22.4%upside
Target: $3.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GDRX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.83 – $2.89
TARGET (TP)$3.50
STOP LOSS$2.63
RISK/REWARD1:2.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.46
52W High$5.81
52W Low$2.61
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $792.32M | $750.26M | $766.55M | $745.42M | $550.70M |
| Gross Profit | $744.11M | $683.34M | $701.48M | $698.71M | $521.11M |
| Gross Margin | 93.9% | 91.1% | 91.5% | 93.7% | 94.6% |
| Operating Income | $65.85M | $-27,007,000 | $1.74M | $13.41M | $-275,719,000 |
| Net Income | $16.39M | $-8,868,000 | $-32,828,000 | $-25,254,000 | $-293,623,000 |
| Net Margin | 2.1% | -1.2% | -4.3% | -3.4% | -53.3% |
| EPS | $0.04 | $-0.02 | $-0.08 | $-0.06 | $-1.07 |
Company Overview
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GDRXBeat Rate
39%
Last 18 quarters
Avg Surprise
+9.1%
EPS vs Estimate
Beats / Misses
7/7
4 met exactly
Latest EPS
$0.08
Q4 2025
EPS Surprise History
Q1 24
0.0%
$0.08vs$0.08
Q2 24
-11.1%
$0.08vs$0.09
Q3 24
-11.1%
$0.08vs$0.09
Q4 24
-11.1%
$0.08vs$0.09
Q1 25
-10.0%
$0.09vs$0.10
Q2 25
0.0%
$0.09vs$0.09
Q3 25
-10.0%
$0.09vs$0.10
Q4 25
-11.1%
$0.08vs$0.09
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.09 | — | — | — |
Q4 2025 | Nov 4, 2025 | $0.09 | $0.08 | -11.1% | ✗ MISS |
Q3 2025 | Aug 6, 2025 | $0.10 | $0.09 | -10.0% | ✗ MISS |
Q2 2025 | May 7, 2025 | $0.09 | $0.09 | 0.0% | = MET |
Q1 2025 | Feb 27, 2025 | $0.10 | $0.09 | -10.0% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $0.09 | $0.08 | -11.1% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $0.09 | $0.08 | -11.1% | ✗ MISS |
Q2 2024 | May 9, 2024 | $0.09 | $0.08 | -11.1% | ✗ MISS |
Q1 2024 | Feb 29, 2024 | $0.08 | $0.08 | 0.0% | = MET |
Q4 2023 | Nov 9, 2023 | $0.06 | $0.06 | 0.0% | = MET |
Q3 2023 | Aug 9, 2023 | $0.06 | $0.07 | +16.7% | ✓ BEAT |
Q2 2023 | May 10, 2023 | $0.06 | $0.07 | +16.7% | ✓ BEAT |
Q1 2023 | Feb 28, 2023 | $0.05 | $0.07 | +40.0% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $0.04 | $0.07 | +72.6% | ✓ BEAT |
Q3 2022 | Aug 8, 2022 | $0.04 | $0.06 | +54.4% | ✓ BEAT |
Q2 2022 | May 9, 2022 | $0.08 | $0.10 | +25.0% | ✓ BEAT |
Q1 2022 | Feb 28, 2022 | $0.10 | $0.09 | -10.0% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | $0.08 | $0.09 | +12.5% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $0.08 | $0.08 | 0.0% | = MET |
Latest News
Loading news...
Frequently Asked Questions about GDRX
What is GDRX's current stock price?
GoodRx Holdings, Inc. (GDRX) is currently trading at $2.86 per share. The stock has moved -0.69% today.
What is the analyst price target for GDRX?
The average analyst price target for GDRX is $3.50, based on 1 analyst.
What sector is GoodRx Holdings, Inc. in?
GoodRx Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is GDRX's market cap?
GoodRx Holdings, Inc. has a market capitalization of $0.97 billion, making it a small-cap company.
Does GDRX pay dividends?
No, GoodRx Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAHCO
AdaptHealth Corp.
$10.61
Mkt Cap: $1.4B
AMPH
Amphastar Pharmaceuticals, Inc.
$28.91
Mkt Cap: $1.3B
COLL
Collegium Pharmaceutical, Inc.
$47.28
Mkt Cap: $1.5B
CTEV
Claritev Corporation
$32.42
Mkt Cap: $0.5B
HSTM
HealthStream, Inc.
$22.03
Mkt Cap: $0.7B
INVA
Innoviva, Inc.
$19.51
Mkt Cap: $1.3B
IRMD
IRadimed Corporation
$99.25
Mkt Cap: $1.3B
LFMD
LifeMD, Inc.
$3.98
Mkt Cap: $0.2B
MDXG
MiMedx Group, Inc.
$5.88
Mkt Cap: $0.9B
PLSE
Pulse Biosciences, Inc.
$14.15
Mkt Cap: $1.0B
Explore stocks similar to GDRX for comparison